Two major shareholder advisory firms are recommending that AmerisourceBergen (ABC) stockholders support a proposal to require the pharmaceutical wholesaler to report the steps being taken to manage financial and reputational risks associated with the opioid crisis.

The firms — Glass Lewis and Institutional Shareholder Services — also recommend shareholders back a proposal to disclose if its board claws back compensation from senior executives due to misconduct and another to split the chief executive and chairman jobs, a move that corporate governance experts often endorse as sound practice. The wholesaler holds its annual shareholder meeting on March 1.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy